Member News provides an opportunity for SDEE members to share news and announcements. September Member News features Montana Molecular, Cure Match, Allele Biotechnology, MaxCyte, and Managed Lab Services.
Montana Molecular has designed a new fluorescent sensor that detects cellular stress. The cell stress sensor is a genetically-encoded fluorescent biosensor that produces very bright fluorescence when the cell endures endoplasmic reticulum (ER) stress or undergoes the unfolded protein response (UPR). A broad host of both chemical compounds and genetic mutations can induce ER stress. The UPR is one of the major stress pathways within the cell, which allows the stress sensor to detect a wide range of stress inducing stimuli, some whose primary target is not the ER. Read more at: http://montanamolecular.com/products/cell-stress-sensor/
CureMatch, which was founded less than two years ago, launched its product earlier this year and has been seeking seed investment as it expands sales and marketing efforts. The bridge round was oversubscribed, with Serra Ventures and tech entrepreneur, Phil Trubey, as major investors. CureMatch is now starting discussions with Series A investors. In addition to its success in attracting financing, CureMatch has also been recognized as one of the top startups in San Diego. Last week CureMatch was selected as one of 15 companies in World Trade Center San Diego’s prestigious MetroConnect program, which provides assistance and a $10,000 award to help companies expand global sales.
After 2 years and millions of dollars of intense development, Allele’s GMP facility for stem cells and their derivatives is open for business, with the first family of personalized iPSC banking clients having gone through initial steps.
MaxCyte has appointed Brad Calvin to Executive Vice President of Global Marketing. In this role, Mr. Calvin is responsible for leading MaxCyte’s marketing function to drive growth of the company’s drug discovery and cell therapy business. Also, MaxCyte will be at next month’s World ADC in San Diego. Now in its 8th year World ADC San Diego is the industry’s pinnacle antibody-drug conjugate event. Specifically focused on ADCs and crafted with the field’s thought-leaders World ADC is the industry’s definitive forum for learning and networking.
MLS has launched a new nonprofit, Boots in Bio, to support veterans in finding careers in the biotech industry. The goal is to provide transitioning veterans the opportunity to develop the skill set, knowledge, and connections that will catapult them into a successful career in the biotech/pharma industry. The launch party on will be held at the New English Brewing Co. on Thursday, September 28.